跳至主要内容
临床试验/NCT00258921
NCT00258921已完成不适用

An International Registry in Essential Hypertension

Sanofi0 个研究点目标入组 31,870 人开始时间: 2004年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Sanofi
入组人数
31,870

研究概览

简要总结

To support physicians in their active management of hypertensive patients. By targeting specific systolic and diastolic blood pressure (BP) figures physicians will closely monitor the BP values and as such will have an individualized control of the treatment in each patient.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Adult hypertensive
  • Either newly diagnosed and untreated
  • or previously treated and uncontrolled Patients of both sexes with essential hypertension

排除标准

  • Known secondary hypertension
  • Known secondary curable hypertension (i.e. pheochromocytoma, aldosterone producing adenoma, Cushing disease). Patients with renal disease are not excluded.

研究者

发起方
Sanofi
申办方类型
Industry

相似试验